Fidelity National Information Services, Inc. (NYSE:FIS) target has been raised by Sterne Agee due to the firm’s belief that the company’s end market trends have shown improvement as its 2013 guidance will probably beat the consensus estimate. The firm keeps its Buy rating on the stock.
Gilead Sciences Inc. (NASDAQ:GILD) agreed to purchase YM Biosciences (AMEX:YMI), influencing Wells Fargo to believe that YM’s main drug possesses a promising and possibly differentiated profile among Jak inhibitors in myelofibrosis and could potentially have applications in other oncology indications. The firm thinks that the Street could be undervaluing the long-term potential of Gilead’s oncology pipeline, and it keeps its Outperform rating on the stock.
Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>
Netflix, Inc. (NASDAQ:NFLX): According to Pacific Crest, continuing trends will likely further support Netflix subscriber growth. The firm thinks that the company has “embedded pricing power,” and its penetration among those who use competing services seems to be growing. The firm keeps its Outperform rating on the stock.
Red Hat, Inc. (NYSE:RHT): Cowen thinks that the company’s recent sell-off has caused the shares to be more interesting due to the company’s positioning to enjoy healthy growth and long term positive trends. The firm keeps its Neutral rating on the stock.
Microsoft Corporation (NASDAQ:MSFT): Barclays claims that PC supply chain data for Windows 8 continues to be negative. The firm has reduced its Q2 2013 Windows Surface estimate to 700k from 2 million, causing the firm to reduce Microsoft’s rice target to $31 from 434. The shares have an Equal Weight rating.
Don’t Miss: 2013: The Year of 4G?